Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer.
暂无分享,去创建一个
H. Samonigg | P. Sevelda | H. Hausmaninger | M. Fridrik | M. Lehnert | W. Hehenwarter | G. Tschurtschenthaler | G. Steger | L. Schiller | D. Manfreda | Günther G. Steger | Paul Sevelda | G. Kemmler | R. Haidinger | R. Kienzer